AI is revolutionizing precision and personalized oncology care by enabling more accurate diagnoses, predicting patient outcomes, and tailoring treatments to individual needs. Through advanced algorithms and machine learning, AI can analyze vast amounts of data, including medical records, genetic
In a significant step toward understanding and combating childhood cancers and congenital disorders, the Gabriella Miller Kids First Pediatric Research Program (Kids First), an initiative of the National Institutes of Health (NIH), has released two comprehensive new datasets. Focusing on childhood
Recent findings illuminate the potential benefits of BIO 300, an oral suspension aimed at improving lung function in COVID-19 patients following hospital discharge. Results from a Phase 2 clinical trial, conducted by Humanetics Corporation, underscore the drug's ability to significantly
Dengue fever, a mosquito-borne viral disease, affects millions of people worldwide, particularly in tropical and subtropical regions. This debilitating illness is transmitted by infected Aedes mosquitoes, leading to severe symptoms and complications for many afflicted individuals. Despite the high
The recent FDA Fast Track designation for BR55, developed by Bracco Imaging, marks a significant milestone in the diagnostic imaging industry. This novel molecular imaging ultrasound contrast agent specifically targets vascular endothelial growth factor receptor 2 (VEGFR2), a receptor highly
Allarity Therapeutics, Inc. has announced the expansion of their Phase 2 clinical trial for stenoparib, a dual PARP/Wnt pathway inhibitor, aimed at treating advanced ovarian cancer. Their recent decision seeks to accelerate the drug's clinical development and work towards FDA regulatory
